Prous Science is a leading scientific information provider in the life sciences committed to fostering advanced knowledge management by delivering access to first-class information services and educational resources.
Established in 1958, the company is internationally renowned for its accurate and state-of-the-art educational products and pioneering scientific information services.
The Prous Science Integrity portal contains data on more than 270,000 compounds with demonstrated biological activity and almost 100,000 patent family records.
Prous Science Integrity incorporates twelve key knowledge areas related to drug research and development: Drugs & Biologics, Targets & Pathways, Genomics, Biomarkers, Organic Synthesis, Experimental Pharmacology, Pharmacokinetics/Metabolism, Clinical Studies, Disease Briefings, Companies & Research Institutions, Literature, and Patents.
|
|
 |
- Access recent and relevant information focused on diverse stages of drug research and development at a click.
- Foster better decision-making.
- Drive higher-quality results in drug research and development.
- Use the Learning Center to develop new approaches to information retrieval and analysis without leaving the Integrity environment.
|
|
|
|
- Includes only carefully refined information.
- Advanced knowledge management tools.
- Updated daily.
- The depth and breadth of content - unmatched by any other resource - places a wealth of refined, structured information at the users' fingertips, fostering innovative decision-making.
- A variety of user-friendly search, browse, print and display and export features enhance your ability to manage data quickly and easily.
|
|
|
|
- Drugs & Biologics: essential chemical and pharmacological information, and the development status of bioactive compounds in the drug pipeline.
- Targets & Pathways: target-based approaches to disease diagnosis and therapeutic intervention.
- Genomics: comprehensive genomics data establishing the foundation that will lead from gene to disease.
- Biomarkers: indicators of normal biological or pathogenic processes that can be objectively measured and evaluated.
- Organic Synthesis: routes of synthesis (schemes, intermediates, reagents, end products) for drugs currently on the market or in development.
- Experimental Pharmacology: data from experimental studies that delineate drug/receptor and enzyme/target cell interactions.
- Pharmacokinetics/Metabolism: data from experimental and clinical studies that delineate the absorption, distribution, metabolism and excretion (ADME) profile of a drug.
- Clinical Studies: Comprehensive information on clinical trials of drugs currently under study or in use in humans.
- Disease Briefings: dynamic executive summaries on the current status and future trends in drug therapy for specific diseases.
- Companies & Research Institutions: essential information on organizations active in the fields of pharmaceuticals and biotechnology.
- Literature: references to current literature, abstracts and proceedings from congresses and symposia and company communications.
- Patents: references to the most recent patent literature, from 11 leading sources, reflecting drug research activity throughout the world.
|
|
